The program, which allows qualifying healthcare providers to purchase outpatient drugs at discounted prices, is a significant source of funding for many healthcare organizations in the state.
Here are four key takeaways from the report:
- The state’s largest 340B hospitals accounted for about 80% of the total revenue, amounting to roughly $500 million. These hospitals made up just 13% of the reporting entities but filled the majority of prescriptions under the program.
- Federally qualified health centers and similar safety-net clinics generated the least revenue from the program.
- The report showed that approximately $87 million, or 14% of total net 340B revenue, was generated through payments from Minnesota’s Medicaid programs.
- Covered entities paid more than $120 million to third-party administrators and contract pharmacies, representing 16% of the gross 340B revenue generated.
